1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow ALL, Childhood: new trials by email Literature Review of ALL, Childhood trials Research Report on ALL, Childhood
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ALL SCTped 2012 FORUM Add-on Study Blina Post HSCT Blinatumomab - ALL, Childhood, Minimal Residual Disease | Phase 2 | Terminated | Prof. Christina Peters | 3 | 2020-12-17 | 2024-01-16 |
Neoplasm, Residual (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia (1) · Leukemia, Lymphoid (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplastic Processes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
blinatumomab (1)
Austria (1) · Belgium (1) · Czechia (1) · Denmark (1) · France (1) · Italy (1) · Norway (1) · Poland (1) · Slovakia (1) · Spain (1)